Unum Therapeutics

Unum Therapeutics

Unum Therapeutics

Unum Therapeutics is a cellular therapeutics company ushering in a new wave in cancer immunotherapy.
Founded
2014
Raised
$161.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$69,200,000
IPO - 2018
$15,000,000
Debt financing - 2017
Square 1 Bank
Team Size
10+
Employees
the home of AI info

Unum Therapeutics Inc. (UMRX)'s Financial Results Comparing With Minerva Neurosciences Inc ...

$69,200,000 IPO
PE HUB

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health
Xconomy

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets
$15,000,000 Debt financing
FinSMEs

Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank